Faculty of Healthcare Administration (FHA)

Global accredited training & certification provider

IGMPI Approvals & Accreditation : Approved by Quality Council of India (QCI) & Accredited Vocational Institution of Ministry of HRD, Government of India, Approved Training Institute of Food Safety and Standards Authority of India (FSSAI), Recognized by Department of Industrial Policy & Promotion, Ministry of Commerce & Industry, Government of India, An ISO 9001:2015 Certified Organisation registered under The Societies Registration Act,1860 Government of India Empanelled under Ministry of Horticulture and Food Processing, Government of Uttar Pradesh, Affiliated with Life Sciences and Food Industry Sector Skills Council (SSC)
Trusted by organizations & training participants in over 30 countries. Training | Certification | Education | Research

26 samples as NSQ and 817 samples as SQ declared by CDSCO in random sampling

15th July 2019

After analysis and testing of 843 samples last month as part of random sampling, Central Drugs Standard Control Organization (CDSCO) declared 817 samples as standard quality (SQ) and 26 samples as not of standard quality (NSQ), spurious and misbranded.

Chennai, West Bengal, Madhya Pradesh, Bihar, Himachal Pradesh, Uttarakhand and Goa are those states in which the manufacturers of these drugs are based.

26 NSQ drugs include telmisartan tablets IP 40 MG (Telmiral 40) manufactured by Crescent Therapeutics Limited, Solan, Himachal Pradesh, amoxycillin and potassium clavulanate tablets IP (Clavage-1000) manufactured by Saitech Medicare Pvt Ltd, Himachal Pradesh, levocetirizine hydrochloride tablets IP 5 MG manufactured by Syncom Health Care Ltd, Dehradun, Uttarakhand, glimepiride tablets IP 3mg manufactured by Ravian Lifescience Pvt Ltd, Haridwar and alprazolam tablets manufactured by Medipol Pharmaceuticals India Pvt Ltd, Himachal Pradesh which failed the test for dissolution based on analysis done by Central Drugs Testing Laboratory (CDTL), Chennai, Regional Drugs Testing Laboratory (RDTL), Guwahati, RDTL, Chandigarh and Central Drugs Laboratory (CDL), Kolkata.

Many other drugs also failed tests for salicylic acid, bacterial endotoxins, particulate contamination etc. at different testing laboratories across the country.

For further enquiries, write to or call us on:
info@igmpiindia.org/ +91 8587838177, +91 8130924488, 0120-2427175, 0120-4375280

Pharmaceuticals | Food | Clinical Research | Healthcare | Medical Coding | Medical Device | Nanotechnology | IPR

Healthcare Newsletter

Featured Article

GMP: A continous process

Mr Vinod Arora, Principal Advisor, IGMPI

IGMPI Placement Blog

Placement Testimonials

Placement testimonials: Our alumni are working with Fortune 500 and global Pharmaceutical, Food and healthcare giants like